首页 | 本学科首页   官方微博 | 高级检索  
检索        

经皮冠状动脉介入术前常规剂量他汀治疗对围手术期心肌损伤无保护作用
引用本文:李汭傧,崔炜,刘凡,谢瑞芹,谷国强,杨晓红,鲁静朝,郑红梅,张冀东.经皮冠状动脉介入术前常规剂量他汀治疗对围手术期心肌损伤无保护作用[J].临床荟萃,2012,27(18):1580-1583.
作者姓名:李汭傧  崔炜  刘凡  谢瑞芹  谷国强  杨晓红  鲁静朝  郑红梅  张冀东
作者单位:河北医科大学第二医院河北省心脑血管病研究所心内科,河北石家庄,050000
摘    要:目的 研究择期经皮冠状动脉介入术(percutaneous coronary intervention,PCI)前常规剂量他汀治疗对围手术期心肌损伤的影响.方法 回顾性分析2006年8月至2010年12月于我院心血管内科住院行择期PCI的冠心病患者共293例,根据术前服用他汀与否分为他汀治疗组和非他汀治疗组.于PCI术后20~24小时采集血标本,检测血浆肌钙蛋白I(cTnI)、肌红蛋白(MYO)水平,作为评估围手术期心肌损伤的指标,并观察住院期间主要不良心血管事件.结果 两组患者基线资料基本均衡.他汀治疗组与非他汀治疗组患者PCI术后cTnI升高的发生率分别为22.0%(37/168)与15.2%(19/125),两组患者间差异无统计学意义(P>0.05);两组患者PCI术后cTnI升高3倍以上的发生率分别为3.6%(6/168)与4.8%(6/125),组间差异无统计学意义(P>0.05);PCI术后MYO升高的发生率分别为0.6%(1/168)与2.4%(3/125),两组患者间差异亦无统计学意义(P>0.05).Logistic回归分析显示,每例患者植入支架数是围手术期心肌梗死唯一的独立预测因子.两组患者住院期间无死亡、心肌梗死、心绞痛复发、紧急血运重建等事件发生.结论 择期PCI前常规剂量他汀治疗并不足以降低围手术期心肌损伤的发生率.需要大规模随机对照研究进一步研究、证实.

关 键 词:胃肿瘤  多态现象  

Routine dosage of statin therapy before percutaneous coronary intervention has no cardio-protection
LI Rui-bin , CUI Wei , LIU Fan , XIE Rui-qin , GU Guo-qiang , YANG Xiao-hong , LU Jing-chao , ZHENG Hong-mei , ZHANG Ji-dong.Routine dosage of statin therapy before percutaneous coronary intervention has no cardio-protection[J].Clinical Focus,2012,27(18):1580-1583.
Authors:LI Rui-bin  CUI Wei  LIU Fan  XIE Rui-qin  GU Guo-qiang  YANG Xiao-hong  LU Jing-chao  ZHENG Hong-mei  ZHANG Ji-dong
Institution:Department of Cardiology,the Second Hospital of Hebei Medical University and Institute of Cardiocerebrovascular Disease of Hebei Province,Shijiazhuang 050000,China
Abstract:Objective This research focuses on the impact of pretreatment with statins of routine dose prior to elective percutaneous coronary intervention(PCI) on periprocedural myocardial injury.Methods From August 2006 to December 2010,293 consecutive patients undergoing elective PCI in our department were retrospectively analyzed,stratified according to the status of preprocedural statin medication.Blood samples were collected 20-24 hours after PCI to test the markers of periprocedural myocardial injury,troponin I(cTnI) and myoglobin(MYO).Major adverse cardiac events in hospital were recorded.Results The incidences of cTnI elevation were 22.0%(37/168) and 15.2%(19/125) in the statin therapy and no statin therapy group respectively.The rate of cTnI elevation ≥ 3×ULN was 3.6%(6/168) and 4.8%(6/125) in two groups,respectively,the incidence of MYO elevation was 0.6%(1/168) and 2.4%(3/125),respectively.In the multivariate model,the number of stents deployed per patient was identifed as the only independent predictor of procedure-related myocardial infarction based on postprocedural cTnI elevation ≥ 3×ULN.No major adverse cardiac events took place in two groups during hospitalization.Conclusion Routine dosage of statin therapy before elective PCI seems to be not enough to prevent periprocedural myocardial injury in elective PCI.
Keywords:coronary disease  angioplasty  transluminal  percutaneous coronary  stents  troponin I  myoglobin
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《临床荟萃》浏览原始摘要信息
点击此处可从《临床荟萃》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号